Generate Biomedicines (GENB) Financials: Revenue & Earnings
GENB$14.78+1.57 +11.90%
$1.90B
Market Cap
—
P/E
—
Forward P/E
—
Score
Generate Biomedicines (GENB) Financials: Revenue & Earnings
GENB price $14.78 +1.57 +11.90%
- Ticker
- GENB
- Price
- $14.78
- Change
- +1.57 +11.90%
- Market cap ?
- $1.90B
- Beta ?
- -0.14
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
GENB fair value Not meaningful. Price $14.78.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.51 | — | 7.75M |
| 2026-08-06 | -0.52 | -0.51 | 6.31M | 5.30M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-01 | ARNOLD FRANCES | Sell | 1.00K | $16.00 | 16.00K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 88, holders +30 vs prior quarter. Ownership 78.19%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FLAGSHIP PIONEERING, LLC | 62.67M | 0 | 0.00% | 1.06B |
| FMR LLC | 5.22M | 1.00M | +23.81% | 88.09M |
| CAPITAL WORLD INVESTORS | 4.22M | 211.48K | +5.28% | 71.12M |
| BRAIDWELL LP | 3.28M | -309.15K | -8.60% | 55.40M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.16M | 46.99K | +2.23% | 36.38M |
| NORGES BANK | 2.09M | 2.09M | New | 35.34M |
| ARCH VENTURE MANAGEMENT, LLC | 1.94M | 0 | 0.00% | 32.80M |
| HARBOURVEST PARTNERS LLC | 1.72M | 0 | 0.00% | 29.05M |
| BLACKROCK, INC. | 1.66M | 1.66M | New | 28.00M |
| BAKER BROS. ADVISORS LP | 1.42M | 0 | 0.00% | 24.02M |
| JPMORGAN CHASE & CO | 1.41M | -1.54M | -52.17% | 23.84M |
| DEEP TRACK CAPITAL, LP | 1.33M | 1.33M | New | 22.50M |
| ARK INVESTMENT MANAGEMENT LLC | 1.28M | 786.21K | +157.74% | 21.67M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.13M | 1.00M | +762.59% | 19.11M |
| HARVARD MANAGEMENT CO INC | 1.11M | 0 | 0.00% | 18.74M |
| NVIDIA CORP | 833.33K | 0 | 0.00% | 14.06M |
| DAVERN CAPITAL PARTNERS, LP | 824.68K | 232.88K | +39.35% | 13.91M |
| SIREN, L.L.C. | 736.10K | 0 | 0.00% | 12.42M |
| GEODE CAPITAL MANAGEMENT, LLC | 735.00K | 616.76K | +521.60% | 12.40M |
| STATE STREET CORP | 526.57K | 526.57K | New | 8.88M |
| AFFINITY ASSET ADVISORS, LLC | 400.00K | 50.00K | +14.29% | 6.75M |
| MORGAN STANLEY | 377.99K | 40.69K | +12.06% | 6.38M |
| UBS GROUP AG | 326.27K | -30.43K | -8.53% | 5.50M |
| SPHERA FUNDS MANAGEMENT LTD. | 245.00K | 60.00K | +32.43% | 4.13M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 224.60K | 224.60K | New | 3.79M |
Earnings and financials
Generate Biomedicines, Inc. (GENB) trades at $14.78, with a market cap of $1.90B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn